Eric Lefkofsky is co-founder and CEO of Tempus Lab. Tempus Lab liaises with healthcare professionals in a variety of disciplines, including physicians and pharmaceutical companies, in a quest to expand the utility of data to improve the effectiveness of patient care and treatment. The focus of Tempus Labs is to expand treatment options for cancer patients and to that end data is collected, digitized, and stored in a searchable database so that critical information is available and accessible. Tempus Labs is a rarity in the world of business startups. Most startups fail within the first four years, but Tempus Labs is now a member of an elite “club” of startups. Tempus Labs is a “unicorn.”
“Unicorn” is a term coined by a venture capitalist named Aileen Lee to describe startups with a valuation of more than $1 billion. Tempus Labs, according to a recent Chicago Tribune article, soared into the ranks of unicorns with recent investments. Tempus Labs and Eric Lefkofsky received a recent investment of $80 million boosting investments to $210 million since 2015. With that infusion of investment dollars, the total valuation of Tempus Labs soared to $1.1 billion, hence the title “unicorn.”
Tempus Labs is thriving in the world of healthcare, and because of the strength of the company, they are increasing their employees by approximately 30 each month. Tempus Labs gathers and analyzes clinical data as well as data from the molecular level of patients receiving cancer treatments, to personalize treatment. This data is stored in an operating system developed by Tempus Labs, a system that enables the individualization of patient care through its “interactive analytical and machine learning platform.” The operating system makes data available in real time allowing physicians to make data-driven decisions that will benefit the lives of their patients.
Eric Lefkofsky and his wife Liz established a charitable foundation known as the Lefkofsky Family Foundation (LFF). Through their foundation, Mr. and Mrs. Lefkofsky fulfill the mission of Tempus Labs, which is to “enhance the quality of human life,” and they do that through their philanthropy. Their philanthropy extends into the areas of education, human rights, medicine, and arts and culture.
For More info: www.crunchbase.com/person/eric-lefkofsky